BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22170313)

  • 1. PpIX fluorescence combined with auto-fluorescence is more accurate than PpIX fluorescence alone in fluorescence detection of non-melanoma skin cancer: an intra-patient direct comparison study.
    van der Beek N; de Leeuw J; Demmendal C; Bjerring P; Neumann HA
    Lasers Surg Med; 2012 Apr; 44(4):271-6. PubMed ID: 22170313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin.
    Kulyk O; Ibbotson SH; Moseley H; Valentine RM; Samuel ID
    Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):630-9. PubMed ID: 26467274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of photodynamic diagnosis in defining the lateral border between a tumor and a tumor-free area during Mohs micrographic surgery.
    Lee CY; Kim KH; Kim YH
    Dermatol Surg; 2010 Nov; 36(11):1704-10. PubMed ID: 20840493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The time-dependent accumulation of protoporphyrin IX fluorescence in nodular basal cell carcinoma following application of methyl aminolevulinate with an oxygen pressure injection device.
    Blake E; Campbell S; Allen J; Mathew J; Helliwell P; Curnow A
    J Photochem Photobiol B; 2012 Dec; 117():97-103. PubMed ID: 23092624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Barysch MJ
    Praxis (Bern 1994); 2016 Sep; 105(18):1071-7. PubMed ID: 27606914
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunohistochemical staining for p16 is a useful adjunctive test in the diagnosis of Bowen's disease.
    Harvey NT; Leecy T; Wood BA
    Pathology; 2013 Jun; 45(4):402-7. PubMed ID: 23635817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma.
    Dögnitz N; Salomon D; Zellweger M; Ballini JP; Gabrecht T; Lange N; van den Bergh H; Wagnières G
    J Photochem Photobiol B; 2008 Dec; 93(3):140-8. PubMed ID: 18818091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on non-melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring.
    Lallas A; Argenziano G; Zendri E; Moscarella E; Longo C; Grenzi L; Pellacani G; Zalaudek I
    Expert Rev Anticancer Ther; 2013 May; 13(5):541-58. PubMed ID: 23617346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative study of in vivo protoporphyrin IX fluorescence build up during occlusive treatment phases.
    Campbell CL; Brown CTA; Wood K; Salvio AG; Inada NM; Bagnato VS; Moseley H
    Photodiagnosis Photodyn Ther; 2017 Jun; 18():204-207. PubMed ID: 28257944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
    Tyrrell JS; Campbell SM; Curnow A
    Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
    Tyrrell JS; Morton C; Campbell SM; Curnow A
    Br J Dermatol; 2011 Jun; 164(6):1362-8. PubMed ID: 21564050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
    Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
    J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodetection of basal cell carcinoma using methyl 5-aminolaevulinate-induced protoporphyrin IX based on fluorescence image analysis.
    Won Y; Hong SH; Yu HY; Kwon YH; Yun SJ; Lee SC; Lee JB
    Clin Exp Dermatol; 2007 Jul; 32(4):423-9. PubMed ID: 17459066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence detection and diagnosis of non-melanoma skin cancer at an early stage.
    de Leeuw J; van der Beek N; Neugebauer WD; Bjerring P; Neumann HA
    Lasers Surg Med; 2009 Feb; 41(2):96-103. PubMed ID: 19226578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different Immunohistochemical Localization of Fatty Acid Binding Protein 5 in Actinic Keratosis Compared with That in Bowen's Disease: A Retrospective Study.
    Ahn B; Kim CH; Chae YS; Lee JH; Lee Y; Ahn HH; Lee YJ
    Am J Dermatopathol; 2021 May; 43(5):356-361. PubMed ID: 33055535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The wider application of photodynamic therapy in dermatology].
    Thissen MR; Kuijpers DI; Neumann HA
    Ned Tijdschr Geneeskd; 2005 Jan; 149(5):232-7. PubMed ID: 15719833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic changes after photodynamic therapy for Basal cell carcinoma and Bowen disease: a histologic and immunohistochemical investigation.
    Fantini F; Greco A; Cesinaro AM; Surrenti T; Peris K; Vaschieri C; Marconi A; Giannetti A; Pincelli C
    Arch Dermatol; 2008 Feb; 144(2):186-94. PubMed ID: 18283175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
    Tyrrell J; Campbell SM; Curnow A
    Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):30-8. PubMed ID: 21333932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of protoporphyrin IX by aminolaevulinic acid in actinic keratosis, psoriasis and normal skin: preferential porphyrin enrichment in differentiated cells.
    Smits T; van Laarhoven AI; Staassen A; van de Kerkhof PC; van Erp PE; Gerritsen MJ
    Br J Dermatol; 2009 Apr; 160(4):849-57. PubMed ID: 19175603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phasor-FLIM as a Screening Tool for the Differential Diagnosis of Actinic Keratosis, Bowen's Disease, and Basal Cell Carcinoma.
    Luo T; Lu Y; Liu S; Lin D; Qu J
    Anal Chem; 2017 Aug; 89(15):8104-8111. PubMed ID: 28661125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.